2022-10-01 2023-09-30 false Capium Accounts Production 1.1 09177389 bus:AbridgedAccounts 2022-10-01 2023-09-30 09177389 bus:FRS102 2022-10-01 2023-09-30 09177389 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 09177389 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 09177389 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 09177389 2022-10-01 2023-09-30 09177389 2023-09-30 09177389 bus:RegisteredOffice 2022-10-01 2023-09-30 09177389 core:WithinOneYear 2023-09-30 09177389 core:AfterOneYear 2023-09-30 09177389 bus:Director1 2022-10-01 2023-09-30 09177389 bus:Director1 2023-09-30 09177389 bus:Director1 2021-10-01 2022-09-30 09177389 2021-10-01 09177389 bus:CompanySecretary1 2022-10-01 2023-09-30 09177389 bus:LeadAgentIfApplicable 2022-10-01 2023-09-30 09177389 2021-10-01 2022-09-30 09177389 2022-09-30 09177389 core:WithinOneYear 2022-09-30 09177389 core:AfterOneYear 2022-09-30 09177389 bus:EntityAccountantsOrAuditors 2021-10-01 2022-09-30 09177389 bus:OrdinaryShareClass1 2022-10-01 2023-09-30 09177389 bus:OrdinaryShareClass1 2023-09-30 09177389 bus:OrdinaryShareClass1 2021-10-01 2022-09-30 09177389 bus:OrdinaryShareClass1 2022-09-30 09177389 core:FurnitureFittings 2022-10-01 2023-09-30 09177389 core:FurnitureFittings 2023-09-30 09177389 core:FurnitureFittings 2022-09-30 09177389 core:ComputerEquipment 2022-10-01 2023-09-30 09177389 core:ComputerEquipment 2023-09-30 09177389 core:ComputerEquipment 2022-09-30 09177389 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 09177389 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-09-30 09177389 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 09177389 core:CostValuation core:Non-currentFinancialInstruments 2022-09-30 09177389 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-09-30 09177389 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-09-30 09177389 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-09-30 09177389 core:Non-currentFinancialInstruments 2023-09-30 09177389 core:Non-currentFinancialInstruments 2022-09-30 09177389 core:ShareCapital 2023-09-30 09177389 core:ShareCapital 2022-09-30 09177389 core:RetainedEarningsAccumulatedLosses 2023-09-30 09177389 core:RetainedEarningsAccumulatedLosses 2022-09-30 09177389 dpl:Item1 2022-10-01 09177389 dpl:Item1 2023-09-30 09177389 dpl:Item1 2021-10-01 09177389 dpl:Item1 2022-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09177389
England and Wales

 

 

 

JAS MEDICAL LTD


Abridged Accounts
 


Period of accounts

Start date: 01 October 2022

End date: 30 September 2023
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 September 2023 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
COOLHEADS CONSULTANCY
30 September 2023



....................................................
COOLHEADS CONSULTANCY
221 Extere Road

Harrow
HA2 9PF
05 April 2024
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 2,110    2,813 
2,110    2,813 
Current assets      
Cash at bank and in hand 185,964    165,352 
Creditors: amount falling due within one year (18,114)   (19,069)
Net current assets 167,850    146,283 
 
Total assets less current liabilities 169,960    149,096 
Net assets 169,960    149,096 
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 169,959    149,095 
Shareholder's funds 169,960    149,096 
 


For the year ended 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 05 April 2024 and were signed by:


-------------------------------
THAMBIAYAH SENTHILKUMAR
Director
2
General Information
JAS MEDICAL LTD is a private company, limited by shares, registered in England and Wales, registration number 09177389, registration address 281 South Lane, New Malden, Surrey, KT3 5RR.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 25% Reducing Balance
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Computer Equipment   Total
  £   £   £
At 01 October 2022 423    3,030    3,453 
Additions    
Disposals    
At 30 September 2023 423    3,030    3,453 
Depreciation
At 01 October 2022 30    610    640 
Charge for year 98    605    703 
On disposals    
At 30 September 2023 128    1,215    1,343 
Net book values
Closing balance as at 30 September 2023 295    1,815    2,110 
Opening balance as at 01 October 2022 393    2,420    2,813 


4.

Share Capital

Authorised
100 Class A shares of £0.01 each
Allotted, called up and fully paid
2023
£
  2022
£
100 Class A shares of £0.01 each  
 

3